Showing all 2 results
Reta peptide is an experimental, next-generation metabolic medication developed by Eli Lilly. It is being studied primarily for the treatment of severe obesity and type 2 diabetes.
Retatrutide peptide is an experimental, next-generation medication designed to treat obesity, type 2 diabetes, and related metabolic conditions.
